About
21.76CHF-0.18 -0.82%
Closed • Updated at 20:12 GMT+00:00Market Cap$1.09B
P/E Ratio473.04
Volume161.1K
Beta1.59
RSI50.95
Gross Margin86.44%
Kuros Biosciences Ltd. — investor relations, events, news, and company updates on 6ix.
Latest News
May 7 2026
Kuros Biosciences appoints I.V. Hall as Chief Operating Officer, deepening operational, R&D and extremities leadership for next phase of growth
Apr 14 2026
Kuros Biosciences reports 51% year-over-year increase in sales in the first three months of 2026
Mar 10 2026
Kuros Biosciences delivers 72% year-over-year sales growth, reaching USD 146.1 million for 2025
Jan 13 2026
Kuros Biosciences to provide investor update at Octavian and Baader Bank Conferences
Dec 2 2025
Kuros Biosciences announces enrollment of first patient in ASTRA study – A global, prospective, randomized, multi-center clinical trial in foot and ankle fusion
Community Chat
Ask AI
Try asking
Google Übersetzer